Drug intelligence / Profile preview

Arouse

Development stage
Phase 3
Lead developer
Dosist
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Inhalation
01

Overview

**Arouse** is a dosist dose-controlled inhaled cannabis formulation marketed for sensory enhancement, mood elevation, and energy rather than for a defined disease indication. The original Arouse dose-pen formulation was described as a 10:1 tetrahydrocannabinol to cannabidiol cannabis-oil product with plant-derived terpenes, including linalool; each inhaled dose was designed to deliver approximately 2.5 mg of total cannabis extract. Its principal pharmacology is attributable to delta-9-tetrahydrocannabinol activity at cannabinoid receptors, while cannabidiol and terpenes may modify the overall subjective and sensory profile. Arouse has no established FDA-approved therapeutic indication or clinical development program. ([herb.co](https://herb.co/products/vape-pens/dosist-arouse-dose-pen-100))

Brand names
Arouse
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Arouse.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arouse.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call